List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 19 studies with search of: Behcet's Disease
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Safety and Efficacy of AIN457 in Behçet's Patients With Posterior or Panuveitis
Condition: Behcet Disease
Interventions: Biological: AIN457;   Biological: Placebo
2 Not yet recruiting Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease
Conditions: Behcet Syndrome;   Uveal Disease
Intervention: Drug: Etanercept, Methotrexate, Prednisolone
3 Recruiting Stem Cell Transplantation in Ocular Lesions of Behcet's Disease
Conditions: Retinitis;   Behcet's Syndrome
Intervention: Biological: Autologous Stem Cell Transplantation
4 Recruiting Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease
Conditions: Ocular Behcet's Disease,;   Non-Infectious Uveitis;   Refractory Uveitis
Intervention: Drug: flucinolone acetonide
5 Recruiting Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB)
Conditions: Behcet's Disease;   Panuveitis;   Posterior Uveitis;   Retinal Vasculitis
Interventions: Drug: Cyclosporin A;   Drug: Interferon-alpha2a
6 Completed HAT in Eye Complications of Behcet's Disease
Conditions: Behcet's Syndrome;   Retinal Disease;   Uveitis
Intervention: Drug: Daclizumab
7 Completed Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's Disease
Condition: Behcet's Syndrome
Interventions: Drug: Colchicine;   Drug: Placebo
8 Completed
Has Results 		Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcet's Disease
Conditions: Behcet Syndrome;   Behcet Disease;   Mucocutaneous Ulceration
Intervention: Biological: Veldona,
9 Completed Psychological Symptoms in Patients With Behcet's Disease by SCL90-R
Condition: Behcet's Syndrome
Intervention:
10 Completed Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease
Condition: Behcet's Syndrome
Interventions: Drug: Rituximab;   Drug: Cytotoxic Combination
11 Recruiting A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease
Condition: Behcet Syndrome
Interventions: Drug: Apremilast (CC-10004);   Drug: Placebo
12 Recruiting Studies of the Natural History and Pathogenesis and Outcome of Neonatal Onset Multisystem Inflammatory Disease (NOMID/CAPS, DIRA, CRMO, Still's Disease, Behcet's Disease, and Other Undifferentiated Autoinflammatory Diseases)
Conditions: Urticaria;   Arthropathy;   Lymphadenopathy;   Nervous System Anomalies
Intervention:
13 Recruiting Uveitis Gene-Expression Profiling
Condition: Uveitis
Intervention:
14 Recruiting Hematopoietic Stem Cell Support in Vasculitis
Condition: Vasculitis
Intervention: Procedure: High Dose Immune Suppression with Hematopoietic Stem Cell Transplant
15 Recruiting Safety and Efficacy of AIN457 in Noninfectious Uveitis
Condition: Active Uveitis That is Not From an Infection.
Interventions: Drug: AIN457 type 1;   Drug: AIN457 type 2
16 Completed Evaluation and Treatment of Patients With Inflammatory Eye Diseases
Conditions: Choroiditis;   Iridocyclitis;   Iritis;   Retinal Disease
Intervention:
17 Terminated Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein Levels
Conditions: Coronary Artery Disease;   Inflammatory Response;   Atherosclerosis
Intervention: Dietary Supplement: eicosapentaenoic acid (EPA),
18 Completed Biological Markers in Retinal Vasculitis
Condition: Retinal Vasculitis
Intervention:
19 Enrolling by invitation Stem Cell Transplantation for the Treatment of Knee Osteoarthritis
Condition: Knee Osteoarthritis
Intervention: Biological: Autologous Stem Cell Transplantation

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services